# Cambria Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cambria-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.cambriapharma.com
- Total disclosed funding: $5.4M
- Latest round: Series A (Apr 22, 2008)
- Investors on record: 2

## About

Cambria Pharmaceuticals is a US-based biopharmaceutical company that operates as a manufacturer of treatments for disabling neurological disorders.

## Funding rounds

- Series A, Apr 22, 2008, $5.4M — Converge Venture Partners, Biogen Idec New Ventures

## Investors

- Converge Venture Partners (https://capitalatlas.ai/funds/converge-venture-partners) — Series A
- Biogen Idec New Ventures (https://capitalatlas.ai/funds/biogen-idec-new-ventures) — Series A